Hoy, 23 de agosto, a las 3:01 (EDT) va a haber una teleconferencia dónde expertos de la FDA, el NIH y el CDC (Harvey, Lo, Witten, Nakashi, Monroe) responderán a preguntas sobre el estudio que está embargado por el PNAS hasta las 3:00 (EDT) --> si no me equivoco, hasta las 9 de la noche de aquí.
Como no vamos a poder seguirlo por teléfono, tendremos que esperar que alguien publique algo. Estaremos "al loro"
[t]Scientists to discuss research on XMRV in blood, chronic fatigue syndrome[/t]
What:
Telebriefing by experts from the Food and Drug Administration, the National Institutes of Health and the Centers for Disease Control and Prevention to respond to questions about this study. The paper is currently under embargo until Monday, August 23 at 3:00 p.m., by the Proceedings of the National Academy of Sciences.
Who:
Harvey Alter, M.D., Chief, Clinical Studies and Associate Director for Research, Department of Transfusion Medicine, NIH Clinical Center
Shyh-Ching Lo, M.D., Ph.D., Director, Tissue Safety Laboratory Program, Division of Cellular and Gene Therapies and Division of Human Tissues, Office of Cellular, Tissue and Gene Therapies, Food and Drug Administration Food and Drug Administration
Celia Witten, M.D., Ph.D., Director, Office of Cellular, Tissue and Gene Therapies, Food and Drug Administration
Hira Nakhasi, Ph.D., Director, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Food and Drug Administration
Steve Monroe, Ph.D., Director, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention
When:
Monday, August 23, 3:01 p.m. EDT
How:
Reporters should call 1-888-677-4212 and enter passcode 9258555. For those unable to participate, the briefing will be available on replay approximately two hours after briefing concludes. For replay, dial 1-866-373-4990 and enter passcode 5711.